Clinical Trial Update: Open Label Study of Alefacept Injections to Patients With Moderate to Severe Psoriasis [NA]

View source ↗

Summary

Open-label study of Alefacept injections in patients with moderate to severe psoriasis has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Moderate to Severe

Drugs mentioned

• Alefacept (Alefacept)

Snippet

Sponsor: University of California, San Francisco | Conditions: Moderate to Severe Psoriasis | NA | Status: COMPLETED | Results posted: 2013-02-15